These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4683459)

  • 1. Lymphotoxin in nonspecific inflammatory bowel disease lymphocytes.
    Shorter RG; Huizenga KA; Spencer RJ; Weedon D
    Am J Dig Dis; 1973 Feb; 18(2):79-83. PubMed ID: 4683459
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammatory bowel disease. The role of lymphotoxin in the cytotoxicity of lymphocytes for colonic epithelial cells.
    Shorter RG; Huizenga KA; Spencer RJ; Guy SK
    Am J Dig Dis; 1972 Aug; 17(8):689-96. PubMed ID: 5046733
    [No Abstract]   [Full Text] [Related]  

  • 3. Properties of the inferferon-like virus inhibitor released during interaction of mouse sensitized lymphocytes with their target cells.
    Borecký L; Fuchsberger N; Zemla J; Lackovic V
    Eur J Immunol; 1971 Jun; 1(3):213-8. PubMed ID: 4331347
    [No Abstract]   [Full Text] [Related]  

  • 4. Release of macrophage migration inhibitory factor(s) from lymphocytes stimulated by streptococcal preparations.
    Seravalli E; Taranta A
    Cell Immunol; 1973 Jul; 8(1):40-54. PubMed ID: 4738315
    [No Abstract]   [Full Text] [Related]  

  • 5. Some properties of polyoma virus "T" and "tumour" antigens.
    Zembala M; Ptak W; Porwit-Bobr Z
    Z Immunitatsforsch Exp Klin Immunol; 1970; 141(1):27-36. PubMed ID: 4323568
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphocyte in vitro cytotoxicity: characterization of human lymphotoxin.
    Kolb WP; Granger GA
    Proc Natl Acad Sci U S A; 1968 Dec; 61(4):1250-5. PubMed ID: 5249808
    [No Abstract]   [Full Text] [Related]  

  • 7. An antiviral substance from Penicillium cyaneo-fulvum biourge. 3. Studies on the nature of the antiviral subtance.
    Syeklocha D; Cooke PM; Stevenson JW
    Can J Microbiol; 1967 Nov; 13(11):1481-8. PubMed ID: 6064041
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological expressions of lymphocyte activation. V. Characterization of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells.
    Tadakuma T; Kühner AL; Rich RR; David JR; Pierce CW
    J Immunol; 1976 Jul; 117(1):323-30. PubMed ID: 6595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
    Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
    Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of an immunosuppressive factor from ovarian cancer ascites fluid.
    Oh SK; Moolten FL
    Eur J Immunol; 1981 Oct; 11(10):780-8. PubMed ID: 6273181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of Clostridium difficile toxin in inflammatory bowel disease.
    Rolny P; Järnerot G; Möllby R
    Scand J Gastroenterol; 1983 Jan; 18(1):61-4. PubMed ID: 6144171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endogenous toxemia in nonspecific colitis].
    Golovenko OV; Eroshkina TD; Kirkin BV; Musin II
    Sov Med; 1990; (1):67-9. PubMed ID: 2349521
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pathophysiology of inflammatory bowel diseases and the therapeutic strategy].
    Hibi T; Ogata H
    Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):499-504. PubMed ID: 15052810
    [No Abstract]   [Full Text] [Related]  

  • 14. ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides.
    Hu X; Deng J; Yu T; Chen S; Ge Y; Zhou Z; Guo Y; Ying H; Zhai Q; Chen Y; Yuan F; Niu Y; Shu W; Chen H; Ma C; Liu Z; Guo F
    Gastroenterology; 2019 Mar; 156(4):1098-1111. PubMed ID: 30452920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human lymphotoxin: purification and some properties.
    Granger GA; Laserna EC; Kolb WP; Chapman F
    Proc Natl Acad Sci U S A; 1973 Jan; 70(1):27-30. PubMed ID: 4509662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of anti-lymphocyte antibodies in inflammatory bowel disease.
    Henderson CA; Greenlee L; Williams RC; Strickland RG
    Scand J Immunol; 1976; 5(6-7):837-44. PubMed ID: 790541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further studies pertaining to a B. pertussis factor inhibiting the tuberculin reaction.
    Floersheim GL
    Experientia; 1966 Apr; 22(4):219-20. PubMed ID: 5955984
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of relationship between Clostridium difficile toxin and inflammatory bowel disease in children.
    Hyams JS; McLaughlin JC
    J Clin Gastroenterol; 1985 Oct; 7(5):387-90. PubMed ID: 4067226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A toxin secreted by the soapfish Rypticus saponaceus. A preliminary report.
    Maretzki A; Del Castillo J
    Toxicon; 1967 Feb; 4(4):245-50. PubMed ID: 5618975
    [No Abstract]   [Full Text] [Related]  

  • 20. Somatostatin in the idiopathic inflammatory bowel diseases.
    Koch TR; Carney JA; Morris VA; Go VL
    Dis Colon Rectum; 1988 Mar; 31(3):198-203. PubMed ID: 2894935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.